What are the potential benefits
Tesamorelin & CJC-1295: GHRH analogs in analytical studies CJC-1293, tesamorelin, and CJC-1295) and the primary metabolite of sermorelin in urine, in accordance with WADA requirements
GLP-1 medications do not selectively target belly fat but produce generalized fat loss throughout the body, including significant reductions in abdominal and visceral fat
doi: 10.1038/s41422-020-0332-7 136 MotteLLGiarritielloFSalaLLDragoL
Typical usage protocols include: Fat Loss: 5001,000 mg daily, preferably before fasted cardio Performance Enhancement: 1,0002,000 mg before workouts Medical Use: 50100 mg/kg/day under physician guidance Due to its favorable safety profile, L-Carnitine is often included in ongoing fitness regimens and extended beyond cycle durations